✦ LIBER ✦

Signaling networks and cell cycle control: the molecular basis of cancer and other diseases

✍ Scribed by P. B. Gahan

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 26 KB
Volume: 19
Category: Article
ISSN: 0263-6484
DOI: 10.1002/cbf.925

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Josef Steiner Lecture:CDKs and cell-

The Josef Steiner Lecture:CDKs and cell-cycle control in fission yeast: Relevance to other eukaryotes and cancer

✍ Paul Nurse 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 24 KB 👁 2 views

There are two reasons why cell-cycle control is important for understanding cancer. The first and obvious one is that cancer involves unrestrained cell proliferation resulting in cells losing control and being driven through the cell cycle. The second reason is that cell-cycle control leads to an or

Introduction: Uses of molecular biology:

Introduction: Uses of molecular biology: Understanding the basis of genetic disease, determining evolutionary pathways, and other applications

✍ Jeffrey C. Long 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 3 views

The cell cycle: Principles of control (P

The cell cycle: Principles of control (Primers in Biology series)

✍ Akif Uzman 📂 Article 📅 2007 🏛 The American Society for Biochemistry and Molecula 🌐 English ⚖ 54 KB 👁 1 views

Analysis of Molecular Mechanism of Cance

Analysis of Molecular Mechanism of Cancer Cell Differentiation and Apoptosis Induced by Vitamin D3 Analogues on the Basis of Molecular Recognition of Vitamin D Receptor Ligand Binding Domain

✍ Kimie Nakagawa 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 52 KB

Treatment of patients with acute lymphob

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features : Randomized controlled trial from the Children's Cancer Group

✍ Peter G. Steinherz; Paul S. Gaynon; John C. Breneman; Joel M. Cherlow; Neil J. G 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 2 views

## Background: Children with acute lymphoblastic leukemia with multiple poor prognostic factors and who have a lymphomatous mass at diagnosis, whether of t- or non-t-immunophenotype, are at increased risk of short term remission and extramedullary recurrence, and are in need of better therapies. #